Original article by Jill Margo
The Australian Financial Review – Page: 2 : 11-Jun-20
The Prostate Theranostics & Imaging Centre of Excellence at the Peter MacCallum Cancer Centre will be officially opened on 11 June. It is headed by Michael Hofman, a pioneer in the use of theranostics to treat prostate cancer. Research undertake at 11 cancer centres across Australia has shown that theranostics has higher response rates and fewer side effects than chemotherapy. The new cancer centre has received $7.4m in funding from a foundation established by US philanthropist, convicted insider trader and prostate cancer survivor Mike Milken.
CORPORATES
PETER MACCALLUM CANCER CENTRE
